Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-16 Wheadon David E. Director Grant or award +39,400 86,150
2026-07-16 Wheadon David E. Director Grant or award · Stock Options (right to buy) +78,700 78,700
2025-06-13 Wheadon David E. Director Grant or award +16,000 46,750
2025-06-13 Wheadon David E. Director Grant or award · Stock Option (right to buy) +95,400 95,400
2024-06-11 Wheadon David E. Director Grant or award +16,000 30,750
2024-06-11 Wheadon David E. Director Grant or award · Stock Option (right to buy) +95,400 95,400
2023-06-26 Wheadon David E. Director Grant or award +7,375 14,750
2023-06-26 Wheadon David E. Director Grant or award · Stock Option (right to buy) +44,224 44,224
2022-08-04 Wheadon David E. Director Grant or award +7,375 7,375
2022-08-04 Wheadon David E. Director Grant or award · Stock Option (right to buy) +44,224 44,224
2021-06-16 Wheadon David E. Director Grant or award · Stock Option (right to buy) +65,700 65,700

Page 1 of 1 · 11 trades